Richard C. Hoffman

Phylogix, Inc. develops therapeutic drugs. It conducts research on tissue protection and oncology. The firm develops drug candidates in preclinical development, called FRIL to protect cancer patients from the toxic side-effects of chemotherapy. The company was founded in 1998 and is headquartered in Waltham, MA

Texfi Industries, Inc. manufactures and markets a diverse line of textile products from a variety of raw materials, including natural and synthetic materials. Texfi Blends manufactures products made from textured polyester, flame-retardant polyester, and blends of polyester, rayon, and wool which are sold worldwide to the menswear, women's wear and children's wear apparel, uniform, home furnishings, and export markets. The company was incorporated in Delaware in 1963 and is located in New York city, NY.